CATX
Price
$2.35
Change
-$0.07 (-2.89%)
Updated
May 9 closing price
Capitalization
751.25M
3 days until earnings call
RDNT
Price
$55.74
Change
-$0.64 (-1.14%)
Updated
May 9 closing price
Capitalization
3.55B
Earnings call today
Ad is loading...

CATX vs RDNT

Header iconCATX vs RDNT Comparison
Open Charts CATX vs RDNTBanner chart's image
Perspective Therapeutics
Price$2.35
Change-$0.07 (-2.89%)
Volume$363.97K
Capitalization751.25M
RadNet
Price$55.74
Change-$0.64 (-1.14%)
Volume$1.99M
Capitalization3.55B
CATX vs RDNT Comparison Chart
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. RDNT commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and RDNT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CATX: $2.35 vs. RDNT: $55.74)
Brand notoriety: CATX and RDNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CATX: 50% vs. RDNT: 222%
Market capitalization -- CATX: $751.25M vs. RDNT: $3.55B
CATX [@Medical Specialties] is valued at $751.25M. RDNT’s [@Medical Specialties] market capitalization is $3.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whileRDNT’s FA Score has 1 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 6 TA indicator(s) are bullish while RDNT’s TA Score has 6 bullish TA indicator(s).

  • CATX’s TA Score: 6 bullish, 4 bearish.
  • RDNT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CATX and RDNT are a good buy in the short-term.

Price Growth

CATX (@Medical Specialties) experienced а -8.20% price change this week, while RDNT (@Medical Specialties) price change was +4.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

CATX is expected to report earnings on Aug 08, 2025.

RDNT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDNT($3.55B) has a higher market cap than CATX($751M). RDNT YTD gains are higher at: -20.189 vs. CATX (-26.332). RDNT has higher annual earnings (EBITDA): 293M vs. CATX (-39.08M). RDNT has more cash in the bank: 343M vs. CATX (9.24M). CATX has less debt than RDNT: CATX (2.55M) vs RDNT (1.49B). RDNT has higher revenues than CATX: RDNT (1.62B) vs CATX (0).
CATXRDNTCATX / RDNT
Capitalization751M3.55B21%
EBITDA-39.08M293M-13%
Gain YTD-26.332-20.189130%
P/E RatioN/A962.00-
Revenue01.62B-
Total Cash9.24M343M3%
Total Debt2.55M1.49B0%
FUNDAMENTALS RATINGS
CATX vs RDNT: Fundamental Ratings
CATX
RDNT
OUTLOOK RATING
1..100
344
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
10035
SMR RATING
1..100
9188
PRICE GROWTH RATING
1..100
6559
P/E GROWTH RATING
1..100
10019
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CATX's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for RDNT (96) in the Medical Or Nursing Services industry. This means that CATX’s stock grew somewhat faster than RDNT’s over the last 12 months.

RDNT's Profit vs Risk Rating (35) in the Medical Or Nursing Services industry is somewhat better than the same rating for CATX (100) in the Biotechnology industry. This means that RDNT’s stock grew somewhat faster than CATX’s over the last 12 months.

RDNT's SMR Rating (88) in the Medical Or Nursing Services industry is in the same range as CATX (91) in the Biotechnology industry. This means that RDNT’s stock grew similarly to CATX’s over the last 12 months.

RDNT's Price Growth Rating (59) in the Medical Or Nursing Services industry is in the same range as CATX (65) in the Biotechnology industry. This means that RDNT’s stock grew similarly to CATX’s over the last 12 months.

RDNT's P/E Growth Rating (19) in the Medical Or Nursing Services industry is significantly better than the same rating for CATX (100) in the Biotechnology industry. This means that RDNT’s stock grew significantly faster than CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXRDNT
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 21 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JOEAX12.490.07
+0.56%
JOHCM Emerging Markets Opps Investor
PMEGX57.300.18
+0.32%
T. Rowe Price Instl Mid-Cap Equity Gr
SMNAX28.230.06
+0.21%
Steward Equity Market Neutral A
BALFX34.31-0.03
-0.09%
American Funds American Balanced F1
BRWCX21.98-0.04
-0.18%
MFS Blended Research Growth Eq C

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-2.89%
STRR - CATX
88%
Closely correlated
+5.98%
SHC - CATX
32%
Poorly correlated
-0.76%
FLGT - CATX
26%
Poorly correlated
+6.14%
ANPCF - CATX
26%
Poorly correlated
N/A
PSNL - CATX
24%
Poorly correlated
-2.33%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
-1.14%
ITGR - RDNT
49%
Loosely correlated
-0.90%
NTRA - RDNT
49%
Loosely correlated
-6.53%
GKOS - RDNT
49%
Loosely correlated
-0.64%
TWST - RDNT
46%
Loosely correlated
-5.49%
NNOX - RDNT
45%
Loosely correlated
+1.16%
More